CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients
The test will identify more than 100 pathogens, as well as drug resistance in viruses and bacteria.
Developed by researchers at Yale University, the method, called deterministic barcoding in tissue sequencing, can map thousands of genes at 10 micron resolution.
In their first conference call with investors, PacBio's new CEO and CFO laid out a strategic plan for the company as it weathers the COVID-19 pandemic.
Pacific Biosciences Upgraded to Overweight by JP Morgan
The investment bank also raised its price target for the company to $15, based on PacBio's strategic plan to commercialize its long-read Sequel II system.
The companies will combine the Binx io diagnostic platform with Sherlock Bio's CRISPR technology to create an easy-to-use rapid test for the point of care.